From single genes to gene networks: High-throughput-high-content screening for neurological disease

Neuron

Volumn 68, Issue 2, 2010, Pages 207-217

  Jain, Shushant ^a   Heutink, Peter ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID PRECURSOR PROTEIN; DJ 1 PROTEIN; LEUCINE RICH REPEAT KINASE 2; PRESENILIN 1; PRESENILIN 2;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CELL PROLIFERATION; DENDRITE; EPIGENETICS; GENE AMPLIFICATION; GENE EXPRESSION; GENE INTERACTION; GENE MUTATION; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC SCREENING; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HIGH THROUGHPUT SCREENING; HUMAN; NERVE FIBER; NEUROLOGIC DISEASE; PARKINSON DISEASE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PHOSPHORYLATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYNAPSE VESICLE; BIOLOGICAL MODEL; BIOLOGY; GENE; GENE EXPRESSION REGULATION; GENETICS; MICROARRAY ANALYSIS; NERVOUS SYSTEM DISEASES; PHYSIOLOGY; PROCEDURES;

COMPUTATIONAL BIOLOGY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENES; GENETIC TESTING; HUMANS; MICROARRAY ANALYSIS; MODELS, BIOLOGICAL; NERVOUS SYSTEM DISEASES;

EID: 77957920012     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2010.10.010     Document Type: Review

References (82)

1. Aherne G.W., McDonald E., Workman P. Finding the needle in the haystack: Why high-throughput screening is good for your health. Breast Cancer Res. 2002, 4:148-154.
2. An W.F., Tolliday N. Cell-based assays for high-throughput screening. Mol. Biotechnol. 2010, 45:180-186.
3. Bettens K., Sleegers K., Van Broeckhoven C. Current status on Alzheimer disease molecular genetics: From past, to present, to future. Hum. Mol. Genet. 2010, 19(R1):R4-R11.
4. Biesecker L.G. Exome sequencing makes medical genomics a reality. Nat. Genet. 2010, 42:13-14.
5. Birmingham A., Selfors L.M., Forster T., Wrobel D., Kennedy C.J., Shanks E., Santoyo-Lopez J., Dunican D.J., Long A., Kelleher D., et al. Statistical methods for analysis of high-throughput RNA interference screens. Nat. Methods 2009, 6:569-575.
6. Birney E., Stamatoyannopoulos J.A., Dutta A., Guigó R., Gingeras T.R., Margulies E.H., Weng Z., Snyder M., Dermitzakis E.T., Thurman R.E., et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007, 447:799-816. ENCODE Project Consortium, NISC Comparative Sequencing ProgramNISC Comparative Sequencing Program, Baylor College of Medicine Human Genome Sequencing CenterBaylor College of Medicine Human Genome Sequencing Center, Washington University Genome Sequencing CenterWashington University Genome Sequencing Center, Broad InstituteBroad Institute, Children's Hospital Oakland Research InstituteChildren's Hospital Oakland Research Institute.
7. Bochdanovits Z., Sondervan D., Perillous S., van Beijsterveldt T., Boomsma D., Heutink P. Genome-wide prediction of functional gene-gene interactions inferred from patterns of genetic differentiation in mice and men. PLoS ONE 2008, 3:e1593.
8. Bonifati V., Rizzu P., van Baren M.J., Schaap O., Breedveld G.J., Krieger E., Dekker M.C., Squitieri F., Ibanez P., Joosse M., et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003, 299:256-259.
9. Botstein D., White R.L., Skolnick M., Davis R.W. Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am. J. Hum. Genet. 1980, 32:314-331.
10. Boutros M., Ahringer J. The art and design of genetic screens: RNA interference. Nat. Rev. Genet. 2008, 9:554-566.
11. Brideau C., Gunter B., Pikounis B., Liaw A. Improved statistical methods for hit selection in high-throughput screening. J. Biomol. Screen. 2003, 8:634-647.
12. Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., et al. The transcriptional landscape of the mammalian genome. Science 2005, 309:1559-1563. FANTOM Consortium, RIKEN Genome Exploration Research Group and Genome Science Group (Genome Network Project Core Group)RIKEN Genome Exploration Research Group and Genome Science Group (Genome Network Project Core Group).
13. Chen L., Feany M.B. Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat. Neurosci. 2005, 8:657-663.
14. Clemons P.A. Complex phenotypic assays in high-throughput screening. Curr. Opin. Chem. Biol. 2004, 8:334-338.
15. Coma I., Herranz J., Martin J. Statistics and decision making in high-throughput screening. Methods Mol. Biol. 2009, 565:69-106.
16. Conrad C., Gerlich D.W. Automated microscopy for high-content RNAi screening. J. Cell Biol. 2010, 188:453-461.
17. Cookson M.R., Bandmann O. Parkinson's disease: Insights from pathways. Hum. Mol. Genet. 2010, 19(R1):R21-R27.
18. Cordell H.J. Detecting gene-gene interactions that underlie human diseases. Nat. Rev. Genet. 2009, 10:392-404.
19. Daub A., Sharma P., Finkbeiner S. High-content screening of primary neurons: Ready for prime time. Curr. Opin. Neurobiol. 2009, 19:537-543.
20. Dragunow M. High-content analysis in neuroscience. Nat. Rev. Neurosci. 2008, 9:779-788.
21. Ebert A.D., Yu J., Rose F.F., Mattis V.B., Lorson C.L., Thomson J.A., Svendsen C.N. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009, 457:277-280.
22. Echeverri C.J., Perrimon N. High-throughput RNAi screening in cultured cells: A user's guide. Nat. Rev. Genet. 2006, 7:373-384.
23. Eglen R.M., Gilchrist A., Reisine T. An overview of drug screening using primary and embryonic stem cells. Comb. Chem. High Throughput Screen. 2008, 11:566-572.
24. Eglen R.M., Gilchrist A., Reisine T. The use of immortalized cell lines in GPCR screening: The good, bad and ugly. Comb. Chem. High Throughput Screen. 2008, 11:560-565.
25. Fan J.B., Chee M.S., Gunderson K.L. Highly parallel genomic assays. Nat. Rev. Genet. 2006, 7:632-644.
26. Gasparri F. Cell-based assays - Informa Life Sciences' Fifth Annual Conference - Cell-based assays for compound screening and 3D assays. IDrugs 2010, 13:520-522.
27. Ge H., Walhout A.J., Vidal M. Integrating 'omic' information: A bridge between genomics and systems biology. Trends Genet. 2003, 19:551-560.
28. Geschwind D.H., Konopka G. Neuroscience in the era of functional genomics and systems biology. Nature 2009, 461:908-915.
29. Gibbs J.R., van der Brug M.P., Hernandez D.G., Traynor B.J., Nalls M.A., Lai S.L., Arepalli S., Dillman A., Rafferty I.P., Troncoso J., et al. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet. 2010, 6:e1000952.
30. Gitler A.D., Chesi A., Geddie M.L., Strathearn K.E., Hamamichi S., Hill K.J., Caldwell K.A., Caldwell G.A., Cooper A.A., Rochet J.C., Lindquist S. Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat. Genet. 2009, 41:308-315.
31. Gorbatyuk O.S., Li S., Sullivan L.F., Chen W., Kondrikova G., Manfredsson F.P., Mandel R.J., Muzyczka N. The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease. Proc. Natl. Acad. Sci. USA 2008, 105:763-768.
32. Grimm S. The art and design of genetic screens: Mammalian culture cells. Nat. Rev. Genet. 2004, 5:179-189.
33. Hertzberg R.P., Pope A.J. High-throughput screening: New technology for the 21st century. Curr. Opin. Chem. Biol. 2000, 4:445-451.
34. Hindorff, L.A., Junkins, H.A., Hall, P.N., Mehta, J.P., and Manolio, T.A. (2010). A Catalog of Published Genome-Wide Association Studies. http://www.genome.gov/gwastudies.
35. Houston J.G., Banks M.N., Binnie A., Brenner S., O'Connell J., Petrillo E.W. Case study: Impact of technology investment on lead discovery at Bristol-Myers Squibb, 1998-2006. Drug Discov. Today 2008, 13:44-51.
36. Inglese J., Johnson R.L., Simeonov A., Xia M., Zheng W., Austin C.P., Auld D.S. High-throughput screening assays for the identification of chemical probes. Nat. Chem. Biol. 2007, 3:466-479.
37. Inglese J., Shamu C.E., Guy R.K. Reporting data from high-throughput screening of small-molecule libraries. Nat. Chem. Biol. 2007, 3:438-441.
38. Katayama S., Tomaru Y., Kasukawa T., Waki K., Nakanishi M., Nakamura M., Nishida H., Yap C.C., Suzuki M., Kawai J., et al. Antisense transcription in the mammalian transcriptome. Science 2005, 309:1564-1566. RIKEN Genome Exploration Research Group, Genome Science Group (Genome Network Project Core Group)Genome Science Group (Genome Network Project Core Group), FANTOM ConsortiumFANTOM Consortium.
39. Kim J.B. Three-dimensional tissue culture models in cancer biology. Semin. Cancer Biol. 2005, 15:365-377.
40. Kim J.B., Stein R., O'Hare M.J. Three-dimensional in vitro tissue culture models of breast cancer- a review. Breast Cancer Res. Treat. 2004, 85:281-291.
41. Krawitz P.M., Schweiger M.R., Rodelsperger C., Marcelis C., Kolsch U., Meisel C., Stephani F., Kinoshita T., Murakami Y., Bauer S., et al. Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome. Nat. Genet. 2010, 42:827-829.
42. Kumar D., Nath L., Kamal M.A., Varshney A., Jain A., Singh S., Rao K.V. Genome-wide analysis of the host intracellular network that regulates survival of Mycobacterium tuberculosis. Cell 2010, 140:731-743.
43. Kunz-Schughart L.A., Heyder P., Schroeder J., Knuechel R. A heterologous 3-D coculture model of breast tumor cells and fibroblasts to study tumor-associated fibroblast differentiation. Exp. Cell Res. 2001, 266:74-86.
44. Kunz-Schughart L.A., Freyer J.P., Hofstaedter F., Ebner R. The use of 3-D cultures for high-throughput screening: The multicellular spheroid model. J. Biomol. Screen. 2004, 9:273-285.
45. Laird P.W. Principles and challenges of genome-wide DNA methylation analysis. Nat. Rev. Genet. 2010, 11:191-203.
46. Macarron R. Critical review of the role of HTS in drug discovery. Drug Discov. Today 2006, 11:277-279.
47. Macarrón R., Hertzberg R.P. Design and implementation of high-throughput screening assays. Methods Mol. Biol. 2009, 565:1-32.
48. Maddox C.B., Rasmussen L., White E.L. Adapting cell-based assays to the high throughput screening platform: Problems encountered and lessons learned. JALA Charlottesv Va 2008, 13:168-173.
49. Maher B. Personal genomes: The case of the missing heritability. Nature 2008, 456:18-21.
50. Makarenkov V., Zentilli P., Kevorkov D., Gagarin A., Malo N., Nadon R. An efficient method for the detection and elimination of systematic error in high-throughput screening. Bioinformatics 2007, 23:1648-1657.
51. Malo N., Hanley J.A., Cerquozzi S., Pelletier J., Nadon R. Statistical practice in high-throughput screening data analysis. Nat. Biotechnol. 2006, 24:167-175.
52. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., McCarthy M.I., Ramos E.M., Cardon L.R., Chakravarti A., et al. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
53. Marazìa S., Barnabei L., De Caterina R. Receiver operating characteristic (ROC) curves and the definition of threshold levels to diagnose coronary artery disease on electrocardiographic stress testing. Part II: The use of ROC curves in the choice of electrocardiographic stress test markers of ischaemia. J. Cardiovasc. Med. (Hagerstown) 2008, 9:22-31.
54. Marchetto M.C., Winner B., Gage F.H. Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases. Hum. Mol. Genet. 2010, 19(R1):R71-R76.
55. Megason S.G., Fraser S.E. Imaging in systems biology. Cell 2007, 130:784-795.
56. Metzker M.L. Sequencing technologies - the next generation. Nat. Rev. Genet. 2010, 11:31-46.
57. Miller J., Arrasate M., Shaby B.A., Mitra S., Masliah E., Finkbeiner S. Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis. J. Neurosci. 2010, 30:10541-10550.
58. Moffat J., Grueneberg D.A., Yang X., Kim S.Y., Kloepfer A.M., Hinkle G., Piqani B., Eisenhaure T.M., Luo B., Grenier J.K., et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 2006, 124:1283-1298.
59. Ng S.B., Buckingham K.J., Lee C., Bigham A.W., Tabor H.K., Dent K.M., Huff C.D., Shannon P.T., Jabs E.W., Nickerson D.A., et al. Exome sequencing identifies the cause of a mendelian disorder. Nat. Genet. 2010, 42:30-35.
60. Park P.J. ChIP-seq: Advantages and challenges of a maturing technology. Nat. Rev. Genet. 2009, 10:669-680.
61. Park I.H., Arora N., Huo H., Maherali N., Ahfeldt T., Shimamura A., Lensch M.W., Cowan C., Hochedlinger K., Daley G.Q. Disease-specific induced pluripotent stem cells. Cell 2008, 134:877-886.
62. Root D.E., Kelley B.P., Stockwell B.R. Detecting spatial patterns in biological array experiments. J. Biomol. Screen. 2003, 8:393-398.
63. Ruano D., Abecasis G.R., Glaser B., Lips E.S., Cornelisse L.N., de Jong A.P., Evans D.M., Davey Smith G., Timpson N.J., Smit A.B., et al. Functional gene group analysis reveals a role of synaptic heterotrimeric G proteins in cognitive ability. Am. J. Hum. Genet. 2010, 86:113-125.
64. Salero E., Hatten M.E. Differentiation of ES cells into cerebellar neurons. Proc. Natl. Acad. Sci. USA 2007, 104:2997-3002.
65. Sato M., Ozawa T., Inukai K., Asano T., Umezawa Y. Fluorescent indicators for imaging protein phosphorylation in single living cells. Nat. Biotechnol. 2002, 20:287-294.
66. Sato M., Kawai Y., Umezawa Y. Genetically encoded fluorescent indicators to visualize protein phosphorylation by extracellular signal-regulated kinase in single living cells. Anal. Chem. 2007, 79:2570-2575.
67. Sepp K.J., Hong P., Lizarraga S.B., Liu J.S., Mejia L.A., Walsh C.A., Perrimon N. Identification of neural outgrowth genes using genome-wide RNAi. PLoS Genet. 2008, 4:e1000111.
68. Smidt M.P., Burbach J.P. How to make a mesodiencephalic dopaminergic neuron. Nat. Rev. Neurosci. 2007, 8:21-32.
69. Stone D.J., Marine S., Majercak J., Ray W.J., Espeseth A., Simon A., Ferrer M. High-throughput screening by RNA interference: Control of two distinct types of variance. Cell Cycle 2007, 6:898-901.
70. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
71. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
72. Thomas N. High-content screening: A decade of evolution. J. Biomol. Screen. 2010, 15:1-9.
73. Thomas C.H., Collier J.H., Sfeir C.S., Healy K.E. Engineering gene expression and protein synthesis by modulation of nuclear shape. Proc. Natl. Acad. Sci. USA 2002, 99:1972-1977.
74. Varma H., Voisine C., DeMarco C.T., Cattaneo E., Lo D.C., Hart A.C., Stockwell B.R. Selective inhibitors of death in mutant huntingtin cells. Nat. Chem. Biol. 2007, 3:99-100.
75. Walhout A.J., Reboul J., Shtanko O., Bertin N., Vaglio P., Ge H., Lee H., Doucette-Stamm L., Gunsalus K.C., Schetter A.J., et al. Integrating interactome, phenome, and transcriptome mapping data for the C. elegans germline. Curr. Biol. 2002, 12:1952-1958.
76. Wernig M., Zhao J.P., Pruszak J., Hedlund E., Fu D., Soldner F., Broccoli V., Constantine-Paton M., Isacson O., Jaenisch R. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. USA 2008, 105:5856-5861.
77. Yeger-Lotem E., Riva L., Su L.J., Gitler A.D., Cashikar A.G., King O.D., Auluck P.K., Geddie M.L., Valastyan J.S., Karger D.R., et al. Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity. Nat. Genet. 2009, 41:316-323.
78. Zhang X.D., Heyse J.F. Determination of sample size in genome-scale RNAi screens. Bioinformatics 2009, 25:841-844.
79. Zhang J.H., Chung T.D., Oldenburg K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 1999, 4:67-73.
80. Zhang J.H., Chung T.D., Oldenburg K.R. Confirmation of primary active substances from high throughput screening of chemical and biological populations: A statistical approach and practical considerations. J. Comb. Chem. 2000, 2:258-265.
81. Zhang E.E., Liu A.C., Hirota T., Miraglia L.J., Welch G., Pongsawakul P.Y., Liu X., Atwood A., Huss J.W., Janes J., et al. A genome-wide RNAi screen for modifiers of the circadian clock in human cells. Cell 2009, 139:199-210.
82. zur Lage P.I., Jarman A.P. The function and regulation of the bHLH gene, cato, in Drosophila neurogenesis. BMC Dev. Biol. 2010, 10:34.